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Spontaneous proliferation, a hallmark of Human-T
Lymphocyte Virus Type 1 (HTLV-1) infection, is parti-
cularly higher in HAM/TSP patients compared to
asymptomatic carriers. However the role of the prolif-
eration in the pathogenesis of HAM/TSP is still
unknown. The identification of drugs that modulate the
spontaneous proliferation may be important for the
treatment of HAM/TSP disease. We have evaluated the
effect of three different quinoline compounds (A, B and
C) on the modulation of spontaneous proliferation of
peripheral blood mononuclear cells from HTLV-1
patients with HAM/TSP. The cells from 8 HAM/TSP
patients were cultivated in the presence of serial concen-
trations of quinolone compounds. Cell proliferation was
assessed by 3[H]thymidine incorporation. Cell viability
was measured by optical density in the presence of
MTT. The ultrastructure analysis was done using a
transmission electron microscope. Quinoline com-
pounds were not toxic at the concentrations evaluated.
The IC50 was 18.5 µM for compound A, 30.5 µM for
compound B and 3.4 µM for compound C. The three
compounds inhibited more than 90% of spontaneous
proliferation. Cultured cells in the presence of quinolone
compounds showed vacuoles presented with myelin-like
membranes, probably autophagic vacuole-like compart-
ments, observed by electronic microscopy. In conclusion,
the quinoline compounds showed no toxicity and were
able to inhibit the spontaneous proliferation of T cells
from HTLV-1-infected individuals. New assessments are
being applied to understand how the quinoline com-
pounds act on cells by decreasing cell proliferation.
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